GLAUKOS Corp·4/A

Jun 23, 7:25 PM ET

WEISNER AIMEE S 4/A

4/A · GLAUKOS Corp · Filed Jun 23, 2026

Research Summary

AI-generated summary of this filing

Updated

GLAUKOS (GKOS) Director Aimee S. Weisner Receives Award

What Happened

  • Aimee S. Weisner, a director of GLAUKOS Corp (GKOS), was granted a derivative award on May 28, 2026 covering 2,987 shares. The grant is reported as an acquisition (award) with an acquisition price of $0.00 and an exercise price of $106.52 per share. The options vest in full on the one-year anniversary (May 28, 2027) and were granted under the issuer’s Director Compensation Policy.
  • This filing is an amendment (Form 4A) correcting the originally reported exercise price; the initial Form 4 filed June 1, 2026 incorrectly listed the exercise price as $53.57.

Key Details

  • Transaction date: 2026-05-28 (grant).
  • Grant amount: 2,987 option shares; exercise price: $106.52 per share; acquisition price reported $0.00.
  • Vesting: Vests in full on the one-year anniversary (per Director Compensation Policy).
  • Filing: Amended Form 4A filed 2026-06-23 to correct exercise price (original filed June 1, 2026).
  • Shares owned after transaction: Not specified in the provided filing.
  • Footnotes: F1 corrects exercise price; F2 confirms grant under Director Compensation Policy and one-year vesting.

Context

  • This was an equity compensation award (options), not a purchase or sale of shares. Options give the holder the right to buy shares later at the exercise price ($106.52); exercising would require payment of that price and may be followed by a sale if the holder chooses. The grant is routinely used for director compensation/retention and does not, by itself, indicate a buy or sell market action.

Insider Transaction Report

Form 4/AAmended
Period: 2026-05-28
Transactions
  • Award

    Stock Option (Right to Buy)

    [F1][F2]
    2026-05-28+2,9872,987 total
    Exercise: $106.52From: 2027-05-28Exp: 2036-05-28Common Stock (2,987 underlying)
Footnotes (2)
  • [F1]This Form 4A amends a Form 4 filed June 1, 2026 that incorrectly reported the exercise price of options granted to the Reporting Person on May 28, 2026 as $53.57. The correct exercise price for the options granted is $106.52, as shown above.
  • [F2]Granted pursuant to the Issuer's Director Compensation Policy. Vests in full on the one-year anniversary of grant date.
Signature
Diana Scherer, Attorney-in-Fact|2026-06-23

Documents

1 file
  • 4
    form4a-06232026_110637.xml